Lidia Flamini

Lidia Flamini is a seasoned professional in regulatory affairs with extensive experience in the pharmaceutical and biotech industries. Currently serving as Global Regulatory Strategy Sr Manager for Biologics at Galderma since April 2023, Lidia leads the regulatory strategy for the submission of nemolizumab across international markets. Prior to this role, Lidia held various positions at GSK from August 2013 to February 2023, including Regulatory Affairs Manager and QRM Champion, where responsibilities encompassed regulatory activities for CNS, Metabolic, and Urology products, as well as oversight of Dermatology and Antiinfectives. Earlier career experiences include roles at Laboratorios Phoenix SAICF, Fada Pharma, Sandoz, Laboratorio Bioquímico Argentino S.R.L, and Teleperformance. Lidia holds an MBA from Universidad de 'San Andrés', a Doctor of Pharmacy (PharmD) from Universidad Kennedy, and various certifications in project management and regulatory affairs.